Biologics License Application for Gardasil(R), Merck\'s Investigational Cervical Cancer Vaccine, Is On Track
2nd Feb 2006, 23:36 GMT
Biologics License Application for Gardasil(R), Merck\'s Investigational Cervical Cancer Vaccine, Is On Track related news:
- Biologics License Application for Gardasil(R), Merck's Investigational Cervical Cancer Vaccine, Is On Track — Nachrichten Ticker - www.finanzen.net
- The First Major Launch of a Cancer Vaccine, Designed to Prevent Human Papillomavirus and Therefore Cervical Cancer, is Expected in 2006 — PR Web (The Free Wire Service) Medical Cancer
- Cervical cancer rates lowest in SA — HEALTH
- Merck vaccine against diarrhea virus wins US OK (Reuters) —
- Merck Vaccine Gets FDA Approval — WSJ.com: US Business
- Merck vaccine against diarrhea virus wins US OK — KeralaNext: US
- FDA Approves Rotavirus Vaccine: Merck Will Sell Oral Drug Developed at Children's Hospital, Wistar — RedOrbit News - Health
- OR-Live.com Presents: da Vinci Radical Hysterectomy for Cervical Cancer — Obstetrics/ Gynecology News from StratCenter.com
- Lipid Sciences Receives Conditional Approval From the FDA of Investigational Device Exemption Application — Pharmaceuticals News from StratCenter.com
- Researchers Report Big Gains Against Cervical Cancer (HealthDay) — Yahoo! News: Health News
Latest news from Newsticker - Hamburger Abendblatt:
- Mehrere Entführungsopfer in Bagdad wieder frei
- Keine Tourismus-Steuer in Italien
- Neues Eilts-Team schlägt Österreich 4:1
- Jüdisches Mahnmal in Hannover beschädigt
- US-Konzern Estée Lauder plant Luxus-Klinik am Flughafen Tempelhof
- Jubel für den neuen Bond bei 007-Weltpremiere
- Blair fordert USA zur Lösung des Israel-Palästina-Konflikts auf
- Blair verlangt von USA neue Gesamtstrategie in Nahost
- Nationalmannschaft spielt gegen Zypern
- Mehrheit der Entführten in Bagdad wieder frei